STRIDES PHARMA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for STRIDES PHARMA, and what generic and branded alternatives to STRIDES PHARMA drugs are available?
STRIDES PHARMA has two hundred and forty-five approved drugs.
There are three tentative approvals on STRIDES PHARMA drugs.
Summary for STRIDES PHARMA
US Patents: | 0 |
Tradenames: | 153 |
Ingredients: | 149 |
NDAs: | 245 |
Patent Litigation for STRIDES PHARMA: | See patent lawsuits for STRIDES PHARMA |
Drugs and US Patents for STRIDES PHARMA
Expired US Patents for STRIDES PHARMA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Strides Pharma | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-001 | Sep 26, 1996 | 5,482,963 | ⤷ Try a Trial |
Strides Pharma | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-003 | Sep 17, 1999 | 5,319,097 | ⤷ Try a Trial |
Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-003 | Approved Prior to Jan 1, 1982 | 5,238,924 | ⤷ Try a Trial |
Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-003 | Approved Prior to Jan 1, 1982 | 4,105,776 | ⤷ Try a Trial |
Strides Pharma | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-001 | Sep 26, 1996 | 5,612,367 | ⤷ Try a Trial |
Strides Pharma | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-003 | Sep 17, 1999 | 4,859,692 | ⤷ Try a Trial |
Strides Pharma | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-001 | Sep 26, 1996 | 6,143,775 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for STRIDES PHARMA drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
➤ Subscribe | Tablets | 10 mg and 20 mg | ➤ Subscribe | 2008-02-29 |
Similar Applicant Names
Here is a list of applicants with similar names.